KPV Peptide Therapy
Benefits, Side Effects, Cost & Protocols
KPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (alpha-MSH). It has potent anti-inflammatory properties and has been studied for inflammatory bowel disease, skin inflammation, and immune modulation without the melanogenic effects of full-length alpha-MSH.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated August 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
How KPV Works
Anti-inflammatory tripeptide that modulates cytokine production and may reduce inflammatory responses without melanotropic effects.
KPV FAQ
What is KPV?
KPV is a tripeptide fragment of alpha-MSH researched for its potent anti-inflammatory properties, particularly in gut and skin applications.
How does KPV work?
Anti-inflammatory tripeptide that modulates cytokine production and may reduce inflammatory responses without melanotropic effects.
Is KPV legal to buy?
KPV is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy KPV?
KPV is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does KPV belong to?
KPV is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.
What are the research benefits of KPV?
KPV has been studied for: Anti-inflammatory, Gut health research, Skin inflammation. Anti-inflammatory fragment; popular for IBD and skin research.
KPV Compound Data
KPV News
In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides - STAT
STAT · 1 month ago
Peptide Safety and Cancer Risk: What You Need to Know - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute · 24 days ago
Peptides: Doctors explain the benefits, risks and FDA concerns - UCHealth
UCHealth · 1 month ago
FDA panel votes to loosen restrictions for controversial peptides - BBC
BBC · 1 month ago
FDA Panel Votes to Loosen Restrictions for Four Peptides - Pharmaceutical Executive
Pharmaceutical Executive · 1 month ago
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore KPV with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in KPV.
Take the Quiz →